When considering the overall survival, high expression of DEFB1 indicated worse prognosis in lung adenocarcinoma (LUAD) and pancreatic adenocarcinoma (PAAD), while the high expression of DEFB1 indicated improved prognosis in HNSC. This evidence concerns the gene DEFB1 and pancreatic adenocarcinoma.